-+ 0.00%
-+ 0.00%
-+ 0.00%

BTIG Downgrades Aardvark Therapeutics to Neutral

Benzinga·05/15/2026 14:42:25
Listen to the news
BTIG analyst Jeet Mukherjee downgrades Aardvark Therapeutics (NASDAQ:AARD) from Buy to Neutral.